Cargando…
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19
COVID-19 is caused by SARS-CoV-2 (SC2) and is more prevalent and severe in elderly and patients with comorbid diseases (CM). Because chitinase 3-like-1 (CHI3L1) is induced during aging and CM, the relationships between CHI3L1 and SC2 were investigated. Here, we demonstrate that CHI3L1 is a potent st...
Autores principales: | Kamle, Suchitra, Ma, Bing, He, Chuan Hua, Akosman, Bedia, Zhou, Yang, Lee, Chang-Min, El-Deiry, Wafik S., Huntington, Kelsey, Liang, Olin, Machan, Jason T., Kang, Min-Jong, Shin, Hyeon Jun, Mizoguchi, Emiko, Lee, Chun Geun, Elias, Jack A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663553/ https://www.ncbi.nlm.nih.gov/pubmed/34747367 http://dx.doi.org/10.1172/jci.insight.148749 |
Ejemplares similares
-
CHI3L1 enhances melanoma lung metastasis via regulation of T cell co-stimulators and CTLA-4/B7 axis
por: Ma, Bing, et al.
Publicado: (2022) -
Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis
por: Lee, Suh-Young, et al.
Publicado: (2022) -
Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19
por: Kamle, Suchitra, et al.
Publicado: (2022) -
Correction: Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3
por: Lee, Chang-Min, et al.
Publicado: (2023) -
Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3
por: Lee, Chang-Min, et al.
Publicado: (2019)